| Date Filed | Type | Description |
| 06/17/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/21/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/19/2020 |
4
| Brownlie Keith L (Director) has filed a Form 4 on Celldex Therapeutics, Inc.|
Txns:
| Granted 11,000 options to buy
@ $10.38, valued at
$114.2k
|
|
| 06/20/2019 |
4
| Brownlie Keith L (Director) has filed a Form 4 on Celldex Therapeutics, Inc.|
Txns:
| Granted 4,500 options to buy
@ $2.78, valued at
$12.5k
|
|
| 02/15/2019 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 09/28/2018 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 08/03/2018 |
4
| Brownlie Keith L (Director) has filed a Form 4 on RXi Pharmaceuticals Corp|
Txns:
| Granted 10,000 shares
@ $0 |
|
| 06/15/2018 |
4
| Brownlie Keith L (Director) has filed a Form 4 on Celldex Therapeutics, Inc.|
Txns:
| Granted 67,000 options to buy
@ $0.6011, valued at
$40.3k
|
|
| 06/16/2017 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 06/16/2017 |
3
| Form 3 - Initial statement of beneficial ownership of securities |
| 06/12/2017 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 02/03/2017 |
4
| Brownlie Keith L (Director) has filed a Form 4 on RXi Pharmaceuticals Corp |
| 06/20/2016 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 02/12/2016 |
4
| Brownlie Keith L (Director) has filed a Form 4 on RXi Pharmaceuticals Corp|
Txns:
| Granted 16,666 options to buy
@ $0.2858, valued at
$4.8k
|
|
| 06/19/2015 |
4
| Brownlie Keith L (Director) has filed a Form 4 on SOLIGENIX, INC.|
Txns:
| Granted 19,868 options to buy
@ $1.51, valued at
$30k
|
|
| 06/02/2015 |
4
| Brownlie Keith L (Director) has filed a Form 4 on RXi Pharmaceuticals Corp|
Txns:
| Granted 16,666 options to buy
@ $0.38, valued at
$6.3k
|
|
| 04/09/2015 |
4
| Brownlie Keith L (Director) has filed a Form 4 on SOLIGENIX, INC.|
Txns:
| Exercised 14,286 warrants
@ $0.61, valued at
$8.7k
|
|
| 06/20/2014 |
4
| Brownlie Keith L (Director) has filed a Form 4 on SOLIGENIX, INC.|
Txns:
| Granted 13,669 options to buy
@ $2.19, valued at
$29.9k
|
|
| 06/11/2014 |
4/A
| Brownlie Keith L (Director) has filed a Form 4 on CANCER GENETICS, INC|
Txns:
| Granted 10,000 options to buy
@ $11.7, valued at
$117k
|
|
| 06/04/2014 |
4
| Brownlie Keith L (Director) has filed a Form 4 on RXi Pharmaceuticals Corp|
Txns:
| Granted 16,666 options to buy
@ $2.85, valued at
$47.5k
|
|
| 05/27/2014 |
4
| Brownlie Keith L (Director) has filed a Form 4 on CANCER GENETICS, INC|
Txns:
| Granted 5,000 shares
@ $0 |
|
| 05/16/2014 |
4
| Brownlie Keith L (Director) has filed a Form 4 on SOLIGENIX, INC.|
Txns:
| Exercised 16,667 options to buy
@ $0.3, valued at
$5k
|
|
| 10/15/2013 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 10/01/2013 |
4
| Brownlie Keith L (Director) has filed a Form 4 on SOLIGENIX, INC.|
Txns:
| Granted 13,275 options to buy
@ $2.26, valued at
$30k
|
|
| 06/26/2013 |
4
| Brownlie Keith L (Director) has filed a Form 4 on SOLIGENIX, INC.|
Txns:
| Bought 19,047 shares
@ $1.05, valued at
$20k
Bought 14,286 warrants
@ $1.65, valued at
$23.6k
|
|
| 06/11/2013 |
4
| Brownlie Keith L (Director) has filed a Form 4 on RXi Pharmaceuticals Corp |
| 03/01/2013 |
3
| Brownlie Keith L (Director) has filed a Form 3 on RXi Pharmaceuticals Corp |
| 07/25/2012 |
4
| Brownlie Keith L (Director) has filed a Form 4 on SOLIGENIX, INC.|
Txns:
| Granted 25,000 options to buy
@ $0.3, valued at
$7.5k
|
|
| 06/25/2012 |
4
| Brownlie Keith L (Director) has filed a Form 4 on EPICEPT CORP|
Txns:
| Granted 60,000 restricted stock units
@ $0 |
|
| 06/24/2011 |
4
| Brownlie Keith L (Director) has filed a Form 4 on SOLIGENIX, INC.|
Txns:
| Granted 300,000 options to buy
@ $0.199, valued at
$59.7k
|
|
| 06/24/2011 |
3
| Brownlie Keith L (Director) has filed a Form 3 on SOLIGENIX, INC. |